TV's cervical cancer plot fuels smear test demand

By Admin
Share
Doctors and GPs are hoping that a cervical cancer storyline in popular UK soap Eastenders will encourage more women to have a smear test. Actress Jo Jo...

Doctors and GPs are hoping that a cervical cancer storyline in popular UK soap Eastenders will encourage more women to have a smear test.

Actress Jo Joyner’s character Tanya Jessop has just been diagnosed with the disease and doctors are now hoping the response to the plot will be similar to when reality television star Jade Goody publicly battled cervical cancer.

Following Goody’s diagnosis in 2008 the world’s leading cancer charity Cancer Research UK saw 10 times the usual volume of visits to its website.

To read the latest edition of Healthcare Global, click here

Local cervical cancer screening units in the UK also reported a rise in the number of women visiting them for smear tests.

Eastender’ Executive Producer Brian Kirkwood commented: “Viewers will see how Tanya, a mother of three, will use her inner determination to deal with what will be one of the toughest challenges of her tests.”

He reminded women they should have smear tests every three years and added cervical cancer was “very treatable” if it was caught early through regular check-ups.

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma